Logo (Tobramycin 01)
Tobramycin Injection, Solution
Product Images NDC 0409-3578
8 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 0409-3578). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula Tobramycin Sulfate (Tobramycin 02)
Chemical structure diagram of Tobramycin, displaying its molecular arrangement including multiple amine, hydroxyl, and sugar ring components. The diagram shows atomic connections typical for an aminoglycoside antibiotic.*
Graphic Reduced Dosage Nomogram (Tobramycin 03)
A reduced dosage nomogram chart showing the relationship between creatinine clearance (mL/min/1.73 m²) on the top horizontal axis and serum creatinine (mg/100 mL) on the bottom horizontal axis versus the percent of normal dosage on the vertical axis. The chart includes a diagonal line illustrating the dosage adjustment scale based on these measurements, with a note indicating that scales have been adjusted to facilitate dosage calculations.*
Logo (Tobramycin 04)
Label Ndc 0409-3577-01 (Tobramycin 05)
Label for Tobramycin Injection USP Pediatric 20 mg/2 mL (10 mg/mL) multiple-dose vial. It includes warnings about sulfites, specifies use for intravenous or intramuscular injection with dilution required for IV use, and indicates distribution by Hospira, Inc., Lake Forest, IL. The label displays the NDC 0409-3577-11 and a partial bar code.*
Principal Display Panel (20 mg/2 mL Vial Tray)
Packaging label for Tobramycin Injection, USP Pediatric 20 mg/2 mL (10 mg/mL) in a 2 mL multiple-dose fliptop vial. The label indicates it is for intramuscular or intravenous use, contains sulfites, and is distributed by Hospira, Inc. The product is prescription only and includes storage instructions and lot information.*
Label Ndc 0409-3578-01 (Tobramycin 07)
The label for Tobramycin Injection, USP, with a strength of 80 mg per 2 mL (40 mg/mL), in a 2 mL multiple-dose vial. It notes the route of administration as intravenous (I.V.) or intramuscular (I.M.) use, includes a warning about sulfites, and states dilution is required for I.V. use. The product is distributed by Hospira, Inc., Lake Forest, IL, USA. The NDC on the label is 0409-3578-11.*
Principal Display Panel (80 mg/2 mL Vial Tray)
TOBRAMYCIN 40 mg/mL injection, USP packaging label for a 2 mL multiple-dose fliptop vial. The label shows 80 mg/2 mL strength and indicates use for intramuscular or intravenous injection. It includes a warning about sulfites and instructions to dilute for intravenous use. Manufactured and distributed by Hospira, Inc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
